Education
About Us
Working with TipRanks
Follow Us
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 15.00M | $ 0.00 | $ 0.00 |
| Gross Profit | $ -58.00K | $ -2.41M | $ 6.65M | $ -734.00K | $ -121.00K |
| Operating Income | $ -58.61M | $ -73.11M | $ -105.64M | $ -60.44M | $ -13.50M |
| EBITDA | $ -49.71M | $ -122.24M | $ -97.29M | $ -70.03M | $ -68.21M |
| Net Income | $ -49.77M | $ -124.65M | $ -101.05M | $ -70.76M | $ -68.37M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 209.03M | $ 185.86M | $ 268.23M | $ 376.98M | $ 19.82M |
| Total Assets | $ 215.30M | $ 188.46M | $ 321.90M | $ 401.99M | $ 22.56M |
| Total Debt | $ 1.38M | $ 362.00K | $ 5.79M | $ 0.00 | $ 0.00 |
| Net Debt | $ -18.78M | $ -185.50M | $ -41.94M | $ -376.98M | $ -19.82M |
| Total Liabilities | $ 11.22M | $ 4.87M | $ 25.61M | $ 12.14M | $ 32.36M |
| Stockholders' Equity | $ 204.08M | $ 183.58M | $ 296.29M | $ 389.84M | $ -9.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -59.86M | $ -60.41M | $ -94.57M | $ -58.59M | $ -10.27M |
| Operating Cash Flow | $ -59.39M | $ -60.38M | $ -87.98M | $ -52.85M | $ -8.72M |
| Investing Cash Flow | $ -154.48M | $ -29.62M | $ -241.86M | $ -5.74M | $ -1.54M |
| Financing Cash Flow | $ 199.00M | $ 80.70M | $ 597.00K | $ 417.47M | $ 30.08M |